Literature DB >> 27431088

Factor VII-activating protease deficiency promotes neointima formation by enhancing leukocyte accumulation.

J-M Daniel1,2, C A Reichel3,4, T Schmidt-Woell1, J Dutzmann2, G Zuchtriegel3,4, F Krombach4, J Herold5, J Bauersachs2, D G Sedding2, S M Kanse6,7.   

Abstract

Essentials Factor VII-activating protease (FSAP) is a plasma protease involved in vascular processes. Neointima formation was investigated after vascular injury in FSAP-/- mice. The neointimal lesion size and the accumulation of macrophages were increased in FSAP-/- mice. This was due to an increased activity of the chemokine (C-C motif) ligand 2 (CCL2).
SUMMARY: Background Factor VII-activating protease (FSAP) is a multifunctional circulating plasma serine protease involved in thrombosis and vascular remodeling processes. The Marburg I single-nucleotide polymorphism (MI-SNP) in the FSAP-coding gene is characterized by low proteolytic activity, and is associated with increased rates of stroke and carotid stenosis in humans. Objectives To determine whether neointima formation after vascular injury is increased in FSAP-/- mice. Methods and Results The neointimal lesion size and the proliferation of vascular smooth muscle cells (VSMCs) were significantly enhanced in FSAP-/- mice as compared with C57BL/6 control mice after wire-induced injury of the femoral artery. Accumulation of leukocytes and macrophages was increased within the lesions of FSAP-/- mice at day 3 and day 14. Quantitative zymography demonstrated enhanced activity of gelatinases/matrix metalloproteinase (MMP)-2 and MMP-9 within the neointimal lesions of FSAP-/- mice, and immunohistochemistry showed particular costaining of MMP-9 with accumulating leukocytes. Using intravital microscopy, we observed that FSAP deficiency promoted the intravascular adherence and the subsequent transmigration of leukocytes in vivo in response to chemokine ligand 2 (CCL2). CCL2 expression was increased in FSAP-/- monocytes but not in the vessel wall. There was no difference in the expression of platelet-derived growth factor (PDGF-BB). Conclusions FSAP deficiency causes an increase in CCL2 expression and CCL2-mediated infiltration of leukocytes into the injured vessel, thereby promoting SMC proliferation and migration by the activation of leukocyte-derived gelatinases. These results provide a possible explanation for the observed association of the loss-of-function MI-SNP with vascular proliferative diseases.
© 2016 International Society on Thrombosis and Haemostasis.

Entities:  

Keywords:  leukocyte; metalloproteases; neointima; serine proteases; smooth muscle

Mesh:

Substances:

Year:  2016        PMID: 27431088     DOI: 10.1111/jth.13417

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  6 in total

1.  Factor VII activating protease (FSAP) influences vascular remodeling in the mouse hind limb ischemia model.

Authors:  Joerg Herold; Steven Nowak; Sawa Kostin; Jan-Marcus Daniel; Alexander Francke; Saravanan Subramaniam; Ruediger C Braun-Dullaeus; Sandip M Kanse
Journal:  Am J Transl Res       Date:  2017-06-15       Impact factor: 4.060

Review 2.  Extracellular RNA in Central Nervous System Pathologies.

Authors:  Katharina Tielking; Silvia Fischer; Klaus T Preissner; Peter Vajkoczy; Ran Xu
Journal:  Front Mol Neurosci       Date:  2019-10-17       Impact factor: 5.639

3.  VEGF-A-Cleavage by FSAP and Inhibition of Neo-Vascularization.

Authors:  Özgür Uslu; Joerg Herold; Sandip M Kanse
Journal:  Cells       Date:  2019-11-06       Impact factor: 6.600

4.  Identification of a Phage Display-Derived Peptide Interacting with the N-Terminal Region of Factor VII Activating Protease (FSAP) Enables Characterization of Zymogen Activation.

Authors:  Sebastian Berge-Seidl; Nis Valentin Nielsen; Armando A Rodriguez Alfonso; Michael Etscheid; Sai Priya Sarma Kandanur; Bengt Erik Haug; Maria Stensland; Bernd Thiede; Merve Karacan; Nico Preising; Sebastian Wiese; Ludger Ständker; Paul J Declerck; Geir Åge Løset; Sandip M Kanse
Journal:  ACS Chem Biol       Date:  2022-09-07       Impact factor: 4.634

5.  Genome-wide analysis of genetic determinants of circulating factor VII-activating protease (FSAP) activity.

Authors:  M Olsson; T M Stanne; A Pedersen; E Lorentzen; E Kara; A Martinez-Palacian; N P Rønnow Sand; A F Jacobsen; P M Sandset; J J Sidelmann; G Engström; O Melander; S M Kanse; C Jern
Journal:  J Thromb Haemost       Date:  2018-08-24       Impact factor: 5.824

6.  Characterization of the enzymatic activity of the serine protease domain of Factor VII activating protease (FSAP).

Authors:  Nis V Nielsen; Elfie Roedel; Dipankar Manna; Michael Etscheid; Jens Preben Morth; Sandip M Kanse
Journal:  Sci Rep       Date:  2019-12-12       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.